Drug or technology

Blood draw

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 14, 2026 · INTERVENTIONAL STUDY

Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)

ClinicalTrials.gov

This is a registry record for an active feasibility trial with no reported results; the design and enrollment are documented but outcomes remain unreported.

PreliminaryBoston Scientific Heart Failure Titration during the randomization phase

Reported

Sample size118

Primary outcome measure 1Change in Left Ventricular End-systolic Dim…

Primary outcome measure 2Percentage of surviving participants at 18…

AUG 11, 2026 · INTERVENTIONAL STUDY

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

ClinicalTrials.gov

This is a completed single-arm feasibility study with no reported results; it describes planned enrollment, interventions, and outcome measures without outcome data.

PreliminaryObesity Virginia Commonwealth University Blood draw

Reported

Actual enrollment38

Primary outcome measure 1Quality of Life-Lite survey (baseline and w…

Primary outcome measure 2Meal recall survey (weeks 1, 4, 8, 12, 20,…

AUG 5, 2026 · INTERVENTIONAL STUDY

Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

ClinicalTrials.gov

This is an active clinical trial registry record with no posted results; it describes a planned intervention study in a high-risk population with gene expression as primary outcome.

PreliminaryNonlinear Aerobic Training Cardiopulmonary exercise test Height, Weight, BMI measure

Reported

Planned enrollment75

Primary outcome measureGene expression patterns of non-neoplastic…

Follow-up duration2 years